Anzeige
Meldung des Tages: Erste Psilocybin-Behandlungen laufen – warum steht Optimi noch bei Pennystock-Level?!

Galderma Group News

Aktie
WKN:  A407X6 ISIN:  CH1335392721 US-Symbol:  GDERF Branche:  Pharmazeutika Land:  Schweiz
157,50 €
-0,15 €
-0,10%
17:01:21 Uhr
Depot/Watchlist
Marktkapitalisierung *
41,47 Mrd. €
Streubesitz
16,67%
KGV
103,51
Dividende
0,16 EUR
Dividendenrendite
0,092%
Index-Zuordnung
-

Galderma Group News

27.02.26 - Businesswire
Galderma’s Nemluvio® (nemolizumab) Demonstrates Long-Term Disease Control in Prurigo Nodularis up to Three Years
Galderma (SIX: GALD) today announced new data from the OLYMPIA open-​label extension study investigating the long-term safety and efficacy of Nemluvio in moderate-​to-severe ...
12.02.26 - Businesswire
We Are All Sculptra: First-of-its-Kind Galderma Initiative to Demonstrate How Everyone Can Benefit from Sculptra’s Regenerative Properties
Galderma (SIX: GALD), the pure-play dermatology category leader, today unveiled We Are All Sculptra , a unique program designed to capture the clinical impact of Sculptra ® across ...
11.02.26 - Businesswire
Galderma Expands Restylane® Portfolio in Japan With Launch of OBT™ Hyaluronic Acid Injectables Restylane Defyne™ and Refyne™
Galderma (SIX: GALD), the pure-play dermatology category leader, has announced the launch of Restylane Defyne and Restylane Refyne: the first OBT‑based hyaluronic acid ...
02.02.26 - Businesswire
Galderma Announces U.S. FDA Acceptance of RelabotulinumtoxinA Biologics License Application Resubmission
Galderma (SIX: GALD) today announced that the U.S. FDA has accepted the BLA resubmission for RelabotulinumtoxinA for the temporary improvement of moderate-​to-severe ...
30.01.26 - Businesswire
Galderma Tackles Menopause-related Skin Changes With Global Survey and Clinical Trial Inclusivity
Galderma (SIX: GALD) has unveiled findings from a global survey of peri- and post-​menopausal women from nine countries exploring the impact of menopause on the skin at the ...
29.01.26 - Businesswire
Galderma Unveils ‘Wake Up To Restylane’, Underscoring Restylane as the Ideal Hyaluronic Acid Treatment for Always-On Natural Beauty
Galderma (SIX: GALD), the pure-play dermatology category leader, has launched ‘Wake Up To Restylane’, a global campaign that showcases Restylane as an everyday beauty ally. ...
22.01.26 - Businesswire
IMCAS 2026: Galderma Showcases the Latest Scientific Advances Behind the Industry’s Broadest Injectable Aesthetics Portfolio
Galderma (SIX: GALD) will present ten posters with the latest updates from across its broad aesthetic portfolio spanning regenerative biostimulation, HA and neuromodulator ...
21.01.26 - Businesswire
Galderma Provides Update on Arbitration Case Regarding Neuromodulator Research and Development Partnership
Galderma (SIX:GALD), the pure-play dermatology category leader, today announced that an International Chamber of Commerce arbitral tribunal issued an award confirming the ...
14.01.26 - Businesswire
TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics
Galderma (SIX: GALD) will present data on its innovative and industry-​leading neuromodulator portfolio at the TOXINS 2026 International Conference in Madrid, Spain from January ...
17.12.25 - Businesswire
New Published Data Confirms Nemluvio® (Nemolizumab) Can Rapidly Relieve Itch and Improve Sleep in as Early as Two Days in Both Atopic Dermatitis and Prurigo Nodularis
Galderma (SIX: GALD), the pure-play dermatology category leader, today released new clinical data confirming nemolizumab’s rapid onset of action on itch and sleep, with significant ...
11.12.25 - Businesswire
Galderma Announces First Patient Enrollment in Study to Assess Nemolizumab in Adults With Chronic Pruritus of Unknown Origin
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the first patient enrollment for its phase II study investigating the efficacy and safety of ...
08.12.25 - dpa-AFX
Galderma erhält mit L'Oréal einen neuen Hauptaktionär
Der Kosmetikkonzern L'Oreal verstärkt sein Engagement beim Schweizer Dermatologiespezialisten Galderma . Die Franzosen wollen 10 Prozent der Galderma-​Anteile von den ...
08.12.25 - Businesswire
Galderma Welcomes Increased Equity Investment From L’Oréal
Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that L’Oréal Groupe intends to increase its equity investment in the company, acquiring ...
05.12.25 - Businesswire
Galderma Opens up New Chapter for Sculptra® with MDR Certification and New Expanded Indication for Body
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the certification of Sculptra for body indications in the European Union (EU) following its ...
04.12.25 - Businesswire
Galderma Secures ‘BBB’ Credit Rating With Positive Outlook from S&P Global Ratings
Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that S&P Global Ratings (S&P) has assigned the company a ‘BBB’ long-term issuer ...
17.03.25 - PR Newswire
Galderma's Differin is helping destigmatize acne care with first in category Roblox experience
Galderma's Differin is helping destigmatize acne care with first in category Roblox experience PR Newswire
20.08.24 - Tippchecker
Märkte weiter Bullish – Aktien im Fokus: Galderma und Xiaomi
TELL me! Episode 052 Der Schweizer Trading Podcast von finanzen.ch
01.04.24 - wallstreetONLINE Redaktion
72 Plus am ersten Tag: Reddit? Douglas? Das ist der eigentliche Gewinner der IPO-Saison
Die euphorische Stimmung an den Märkten sollte derzeit eigentlich die beste Voraussetzung für Newcomer auf dem Börsenparkett sein. Die Kollegen von Smartbroker+ stellen drei ...
22.03.24 - wallstreetONLINE Redaktion
Mega-IPO in der Schweiz: Galderma erobert die Börse im Sturm – Aktie schnellt zweistellig hoch
Die Aktien von Galderma sind am Freitag an der SIX Swiss Exchange um bis zu 18 Prozent hoch gesprungen nach dem Börsen­gang, der als einer der größten in Europa in diesem ...

Newssuche

Videos

newspaper
25.02.26
So beeinflussen Margins DEIN Trading
Börsentäglich ab 18 Uhr Feierabend-​Trading Live. Teilnahme kostenlos mit diesem Link ... Mehr »